NCT03693612 2024-08-28GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsGlaxoSmithKlinePhase 1/2 Completed26 enrolled 47 charts
NCT02599324 2023-11-18Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary TumorsPharmacyclics LLC.Phase 1/2 Completed263 enrolled 34 charts
NCT00471432 2023-08-04OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCanadian Cancer Trials GroupPhase 1 Completed40 enrolled
NCT02071862 2022-07-20Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCalithera Biosciences, IncPhase 1 Completed210 enrolled
NCT01282463 2019-09-09Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaEli Lilly and CompanyPhase 2 Completed148 enrolled 19 charts
NCT00003103 2013-07-03Chemotherapy in Treating Patients With Solid TumorsMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed57 enrolled
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled